| Name | Health Aid Co Inc |
|---|---|
| Organization Name | Health Aid Company, Inc. |
| Location | 4502 N Armenia Ave, Tampa, Florida 33603 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (813) 879-7552 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The need for long term studies to establish the best means of treating Diabetes, was underlined by Prof John Cleland from the University of Hull at the ESC Congress in Munich. Prof Cleland listed the latest treatment available for patients and voiced his concern about the side-effects and efficacy of available anti-diabetic drugs.
PLx Pharma, a pharmaceutical company developing safer formulations of proven non-steroidal anti-inflammatory drugs (NSAIDs), today announced that it has been awarded multiple grants from the National Institutes of Health (NIH) totaling approximately $2,000,000. This funding has been awarded to support further advancement of a range of products currently under development by PLx.
The Innovative Vector Control Consortium and Syngenta announced today that the latest field trials of the new Actellic- 300CS micro-encapsulated formulation demonstrate effective control of pyrethroid resistant mosquitoes on treated construction materials for more than eight months.
SkinMedica, Inc. and New York University announced today that they have entered into a global license agreement to develop novel products to address skin hyperpigmentation based on technology invented at NYU.
Researchers from The Westmead Institute for Medical Research have developed a standardized method of measuring the immune response in islet transplant recipients, helping predict patient outcomes.
› Verified 5 days ago
| NPI Number | 1558306001 |
| Organization Name | HEALTH AID COMPANY, INC. |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 4502 N Armenia Ave, Tampa, FL 33603 |
| Phone Number | 813-879-7552 |
News Archive
The need for long term studies to establish the best means of treating Diabetes, was underlined by Prof John Cleland from the University of Hull at the ESC Congress in Munich. Prof Cleland listed the latest treatment available for patients and voiced his concern about the side-effects and efficacy of available anti-diabetic drugs.
PLx Pharma, a pharmaceutical company developing safer formulations of proven non-steroidal anti-inflammatory drugs (NSAIDs), today announced that it has been awarded multiple grants from the National Institutes of Health (NIH) totaling approximately $2,000,000. This funding has been awarded to support further advancement of a range of products currently under development by PLx.
The Innovative Vector Control Consortium and Syngenta announced today that the latest field trials of the new Actellic- 300CS micro-encapsulated formulation demonstrate effective control of pyrethroid resistant mosquitoes on treated construction materials for more than eight months.
SkinMedica, Inc. and New York University announced today that they have entered into a global license agreement to develop novel products to address skin hyperpigmentation based on technology invented at NYU.
Researchers from The Westmead Institute for Medical Research have developed a standardized method of measuring the immune response in islet transplant recipients, helping predict patient outcomes.
› Verified 5 days ago
| NPI Number | 1902212418 |
| Organization Name | HEALTH AID COMPANY, INC. |
| Type | DME Supplier - Customized Equipment |
| Address | 4502 N Armenia Ave, Tampa, FL 33603 |
| Phone Number | 813-879-7552 |
News Archive
The need for long term studies to establish the best means of treating Diabetes, was underlined by Prof John Cleland from the University of Hull at the ESC Congress in Munich. Prof Cleland listed the latest treatment available for patients and voiced his concern about the side-effects and efficacy of available anti-diabetic drugs.
PLx Pharma, a pharmaceutical company developing safer formulations of proven non-steroidal anti-inflammatory drugs (NSAIDs), today announced that it has been awarded multiple grants from the National Institutes of Health (NIH) totaling approximately $2,000,000. This funding has been awarded to support further advancement of a range of products currently under development by PLx.
The Innovative Vector Control Consortium and Syngenta announced today that the latest field trials of the new Actellic- 300CS micro-encapsulated formulation demonstrate effective control of pyrethroid resistant mosquitoes on treated construction materials for more than eight months.
SkinMedica, Inc. and New York University announced today that they have entered into a global license agreement to develop novel products to address skin hyperpigmentation based on technology invented at NYU.
Researchers from The Westmead Institute for Medical Research have developed a standardized method of measuring the immune response in islet transplant recipients, helping predict patient outcomes.
› Verified 5 days ago
News Archive
The need for long term studies to establish the best means of treating Diabetes, was underlined by Prof John Cleland from the University of Hull at the ESC Congress in Munich. Prof Cleland listed the latest treatment available for patients and voiced his concern about the side-effects and efficacy of available anti-diabetic drugs.
PLx Pharma, a pharmaceutical company developing safer formulations of proven non-steroidal anti-inflammatory drugs (NSAIDs), today announced that it has been awarded multiple grants from the National Institutes of Health (NIH) totaling approximately $2,000,000. This funding has been awarded to support further advancement of a range of products currently under development by PLx.
The Innovative Vector Control Consortium and Syngenta announced today that the latest field trials of the new Actellic- 300CS micro-encapsulated formulation demonstrate effective control of pyrethroid resistant mosquitoes on treated construction materials for more than eight months.
SkinMedica, Inc. and New York University announced today that they have entered into a global license agreement to develop novel products to address skin hyperpigmentation based on technology invented at NYU.
Researchers from The Westmead Institute for Medical Research have developed a standardized method of measuring the immune response in islet transplant recipients, helping predict patient outcomes.
› Verified 5 days ago
Bay Area Pharmacy & Medical Supply Type: Durable Medical Equipment & Medical Supplies Supplier Location: 10549 N Florida Ave, Tampa, Florida 33612 Phone: (813) 221-3131 | |
Bay Area Pharmacy Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2086 W Busch Blvd, Tampa, Florida 33612 Phone: (813) 234-4200 | |
Apria Healthcare Llc Type: Home Infusion Therapy Pharmacy Location: 5471 W Waters Ave, Tampa, Florida 33634 Phone: (813) 885-5568 | |
Health Aid Co Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4502 N Armenia Ave, Tampa, Florida 33603 Phone: (813) 879-7552 | |
Publix Pharmacy #1324 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 8701 West Hillsborough Ave, Tampa, Florida 33615 Phone: (813) 885-5182 |